Simponi Aria 50 mg/4 mL (12.5 mg/mL) injection Images
Generic Name: golimumab
This medication has been identified as Simponi Aria 50 mg/4 mL (12.5 mg/mL) injection. It is supplied by Janssen Biotech, Inc.
Simponi Aria is used in the treatment of Ankylosing Spondylitis; Psoriatic Arthritis; Rheumatoid Arthritis; Polyarticular Juvenile Idiopathic Arthritis and belongs to the drug class TNF alfa inhibitors. There is no proven risk in humans during pregnancy. Simponi Aria 50 mg/4 mL (12.5 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Simponi Aria
- Generic Name
- golimumab
- Strength
- 50 mg/4 mL (12.5 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- TNF alfa inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Janssen Biotech, Inc.
- National Drug Code (NDC)
- 57894-0350
More about Simponi Aria (golimumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (27)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
